Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Competitor Analysis: EpCAM Antagonists

Published by: La Merie S.L.

Published: Apr. 1, 2009 - 12 Pages


Table of Contents


Index
  • EpCAM Antagonists in Oncology
  • Corporate EpCAM Antagonist R&D Pipelines
  • About La Merie

Abstract

The present Competitive Intelligence Report about EpCAM Antagonists provides a competitor evaluation in the field of investigational antibodies and antibody-based constructs targeting epithelial cell adhesion molecule (EpCAM) for treatment of cancer as of April 2009.

Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian, pancreatic and lung cancer. Overexpression of EpCAM has been shown to promote the proliferation, migration and invasiveness of breast cancer cells. Moreover, expression of EpCAM is associated with decreased survival in a number of cancer indications, including breast, gall bladder, bile duct, ovarian and ampullary pancreatic cancer. Most of the currently ongoing projects targeting EpCAM are antibodies or antibody-based constructs with an additional payload or effector function to enhance efficacy. Among these constructs are immunotoxins, immunocytokines and T-cell recruitment via CD3 targeting. Recently, the first EpCAM targeting antibody was recommended for approval in the European Union. Further molecules are being evaluated in ovarian cancer, gastric cancer, small-cell lung cancer, breast cancer and colorectal cancer.

The report includes a compilation of current active projects in research and development of epithelial cell adhesion molecule (EpCAM) targeting antibodies and antibody-based constructs. In addition, the report lists company-specific R&D pipelines of EpCAM Antagonists. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009